Document is current
Any future updates will be listed below
-
Authors
Byrne, Susan M. https://orcid.org/0000-0001-9628-6987
Burleigh, Stephen M.
Fragoza, Robert
Jiang, Yue
Savva, Yiannis
Pabon, Ricky
Kania, Evan https://orcid.org/0000-0002-0266-6610
Rainaldi, Joseph https://orcid.org/0000-0003-4123-0008
Portell, Andrew https://orcid.org/0000-0002-0757-909X
Mali, Prashant https://orcid.org/0000-0002-3383-1287
Briggs, Adrian W. https://orcid.org/0009-0001-1644-658X
- License Information
-
More Information
Article History
Received: 3 October 2024
Accepted: 14 May 2025
First Online: 26 May 2025
Competing interests
: S.M. Byrne, S.M. Burleigh, R.F., Y.J., Y.S., R.P., E.K., and A.W.B. are current or former employees of Shape Therapeutics, Inc. P.M. is a scientific co-founder of Shape Therapeutics, Navega Therapeutics, Pi Bio, Boundless Biosciences, and Engine Biosciences. S.M. Byrne, S.M. Burleigh, Y.S., Y.J., R.F., and A.W.B. are named inventors on Shape Therapeutics patent applications relating to this work, including: WO 2021/216853, WO 2023/077013, and WO 2024/044282. The remaining authors declare no competing interests. The terms of these arrangements have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies.
